Loading company…
Riskpilot
← Back to search
Sign in
Get full access
JB Pharma AB
AB
Active
Org 5595211649
Höbalsgatan 3
Activities of holding companies · NACE 6421
Est. 2025
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 560K
EBITDA margin
97.3%
Equity ratio
97.1%
Financial strength
Net profit 2025
SEK 4,1M
1 employees
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2025
Key figures
Annual report 2025
Revenue
SEK 560K
—
EBITDA
SEK 545K
—
Net profit
SEK 4,1M
—
Total assets
SEK 4,3M
—
Equity
SEK 4,1M
—
Employees
1
—
Company information
Legal name
JB Pharma AB
Org number
5595211649
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
25 februari 2025
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva holdingverksamhet, förvalta värdepapper och bedriva konsultuppdrag inom apotekssektorn samt därmed förenlig verksamhet.
Contact
Address
Höbalsgatan 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Activities of holding companies
Companies in Malmö
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2025
Income statement
SEK thousands
Item
2025
Revenue
560
Staff expenses
−0
EBITDA
545
Depreciation & amort.
—
EBIT
545
Net financials
3 689
Profit before tax
4 234
Tax
−113
Net profit
4 120
Balance sheet
SEK thousands
Item
2025
Total assets
4 270
Equity
4 145
Long-term debt
—
Short-term debt
125
Total debt
125
Financial ratios
5-year trend
EBITDA margin
97.3%
This company
15.8%
Market median
+516% vs market
2025
2025
Equity ratio
97.1%
This company
38.2%
Market median
+154% vs market
2025
2025
Return on equity
99.4%
This company
18.4%
Market median
+440% vs market
2025
2025
Net profit margin
735.8%
This company
8.1%
Market median
+8984% vs market
2025
2025
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
2025
2025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-02-25 – 2025-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
JB
Jehon Baftijaj
Board of Directors
2025
EK
Edona Koxha
Deputy Board Member
2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of JB Pharma AB also hold positions in
0
other companies.
Person
Role here
Other companies
Jehon Baftijaj
Board of Directors
0 companies
Edona Koxha
Deputy Board Member
0 companies